Can a new heart pump outperform the standard during High-Risk angioplasty?
Disease control
Completed
This trial tests whether a new device called SynFlow 3.0 can safely support the heart during high-risk angioplasty (a procedure to open blocked coronary arteries) as well as the standard VA-ECMO device. About 222 people with severe coronary artery disease and a weakened heart (ej…
Phase: NA • Sponsor: ForQaly Medical (Shanghai) Co., Ltd • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC